Literature DB >> 8456301

Immune response in mice that lack the interferon-gamma receptor.

S Huang1, W Hendriks, A Althage, S Hemmi, H Bluethmann, R Kamijo, J Vilcek, R M Zinkernagel, M Aguet.   

Abstract

Interferon-gamma (IFN-gamma) exerts pleiotropic effects, including antiviral activity, stimulation of macrophages and natural killer cells, and increased expression of major histocompatibility complex antigens. Mice without the IFN-gamma receptor had no overt anomalies, and their immune system appeared to develop normally. However, mutant mice had a defective natural resistance, they had increased susceptibility to infection by Listeria monocytogenes and vaccinia virus despite normal cytotoxic and T helper cell responses. Immunoglobulin isotype analysis revealed that IFN-gamma is necessary for a normal antigen-specific immunoglobulin G2a response. These mutant mice offer the possibility for the further elucidation of IFN-gamma-mediated functions by transgenic cell- or tissue-specific reconstitution of a functional receptor.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8456301     DOI: 10.1126/science.8456301

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  535 in total

1.  Viral persistence in vivo through selection of neutralizing antibody-escape variants.

Authors:  A Ciurea; P Klenerman; L Hunziker; E Horvath; B M Senn; A F Ochsenbein; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

Review 2.  Rous-Whipple Award Lecture. Chemical features of peptide selection by the class II histocompatibility molecules.

Authors:  E R Unanue
Journal:  Am J Pathol       Date:  1999-03       Impact factor: 4.307

3.  Poxvirus-induced immunostimulating effects on porcine leukocytes.

Authors:  V Fachinger; T Schlapp; W Strube; N Schmeer; A Saalmüller
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

4.  Exaggerated proinflammatory and Th1 responses in the absence of gamma/delta T cells after infection with Listeria monocytogenes.

Authors:  M J Skeen; E P Rix; M M Freeman; H K Ziegler
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

5.  Biologic consequences of Stat1-independent IFN signaling.

Authors:  M P Gil; E Bohn; A K O'Guin; C V Ramana; B Levine; G R Stark; H W Virgin; R D Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

Review 6.  IFNs and STATs in innate immunity to microorganisms.

Authors:  Thomas Decker; Silvia Stockinger; Marina Karaghiosoff; Mathias Müller; Pavel Kovarik
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

7.  T-bet regulates IgG class switching and pathogenic autoantibody production.

Authors:  Stanford L Peng; Susanne J Szabo; Laurie H Glimcher
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

8.  Induction of IL-15 by TCR/CD3 aggregation depends on IFN-gamma and protects against apoptosis of immature thymocytes in vivo.

Authors:  P Matthys; H Dooms; P Rottiers; T Mitera; L Overgergh; G Leclercq; A Billiau; J Grooten
Journal:  Clin Exp Immunol       Date:  2002-12       Impact factor: 4.330

9.  Dendritic Cell RIPK1 Maintains Immune Homeostasis by Preventing Inflammation and Autoimmunity.

Authors:  Joanne A O'Donnell; Jesse Lehman; Justine E Roderick; Dalia Martinez-Marin; Matija Zelic; Ciara Doran; Nicole Hermance; Stephen Lyle; Manolis Pasparakis; Katherine A Fitzgerald; Ann Marshak-Rothstein; Michelle A Kelliher
Journal:  J Immunol       Date:  2017-12-06       Impact factor: 5.422

10.  Gamma interferon-dependent protection of the mouse upper respiratory tract following parenteral immunization with a respiratory syncytial virus G protein fragment.

Authors:  Helene Plotnicky-Gilquin; Dominique Cyblat-Chanal; Jean-Pierre Aubry; Thierry Champion; Alain Beck; Thien Nguyen; Jean-Yves Bonnefoy; Nathalie Corvaïa
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.